Produced by The King's Fund Information & Library Service, this current awareness service brings together the latest policy, guidance, research and reports related to health management and commissioning.
Please note, The King’s Fund does not necessarily endorse the views expressed in content not published by The King’s Fund, unless otherwise stated.
Sign up for this free, twice-weekly alert here: http://www.kingsfund.org.uk/forms/get-latest-news-fund
This online resource has been designed to support commissioners and services in meeting the drug strategy outcomes. It features evidence and guidance; case studies of local initiatives; and links to other useful material.
This document sets out case studies using service delivery models that provide benefits for patients and staff. The clinical teams have shared their learning so that their experiences may be a stimulus to others to improve local interventional radiology services.
The publication of these monthly reports promotes transparency and accountability across Government and allows people to check that departments are meeting their commitments. This report details the progress of structural reform in the Department of Health during June 2012.
These standards propose that services invest in the psychosocial development and well-being of young people with substance misuse problems to give them the best chance of a normal life. They have been developed in partnership with substance misuse organisations, paediatricians, psychologists and nurses.
This discussion paper aims to stimulate thinking on how best to measure outcomes for people with advanced cancer within the NHS. It uses an assessment of the NHS Outcomes Framework indicators and feedback from the RCF’s Patients’ Army to work out what matters to patients with advanced cancer and whether outcomes for this group of patients are represented within the health reforms.
This discussion paper analyses data from NHS London and NHS North West, which found that around 10% of Cancer Drugs Fund approvals were for off-label treatments. This represents an improvement of between 39% and 51% since RCF's last analysis in 2009. It makes recommendations for how recent policy developments could be capitalised on to position England as a leader in research into off-label prescribing, through ensuring enrolment in clinical trials and effective data collection on those patients who access drugs through the Cancer Drugs Fund.
This review of cancer commissioning examines the role that cancer networks play in the new health care landscape. It highlights concerns that there will be a negative impact on the provision of cancer care from the NHS reforms and that recent progress made over the past decade may be jeopardised. It also identifies important strengths and weaknesses in the new commissioning arrangements and offers recommendations for future consideration.
This reportexamines key trends and variations in the delivery of healthcare across the four nations of the UK. It finds that, despite the shared history and similarities between the four nations, there are considerable variations in areas such as health outcomes, spending, staffing and quality.